Providence Portland Medical Center
In research, Providence Portland Medical Center stands highest in Medicine (#3,871 of 10,443 worldwide) and Health Sciences (#4,958 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Immunology, Oncology and Immunology and Microbiology — Immunology is 23.4× its share of world research.
- World rank, 2022–2025
- #5,384 of 28,054 · #5,143 all time
- Rank in United States
- #733 of 4,192
- Research works
- 806 ▲ 19% vs 2013–17
- Citations
- 25k 31.6 per fractional work
- Top-10% rate
- 15.3% record average 16.5%
- Open access
- 39% world 28%
What is Providence Portland Medical Center known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #3,871 of 10,443 | 15.2% | 104 | #4106 | |
| Health SciencesDomain | #4,958 of 11,982 | 15.0% | 110 | #4186 |
Each strip is that field’s whole ranked pool, with the notch where Providence Portland Medical Center sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Providence Portland Medical Center specialise in?
Where its research is concentrated relative to its size: Immunology takes 23.4× the share of its output that it takes of world research.
- ImmunologySubfield · 28.0 works23×
- OncologySubfield · 44.0 works23×
- Immunology and MicrobiologyField · 28.9 works17×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 16.5×. Every wedge is a field page.
- Immunology and Microbiology 16.5×
- Medicine 3.1×
- Biochemistry, Genetics and Molecular Biology 2.6×
- Dentistry 1.6×
- Health Professions 1.0×
- Psychology 0.3×
- Pharmacology, Toxicology and Pharmaceutics 0.2×
- Nursing 0.2×
- Neuroscience 0.2×
- Economics, Econometrics and Finance 0.2×
- Engineering 0.1×
- Chemistry 0.1×
- Computer Science 0.1×
- Physics and Astronomy 0.1×
- Business, Management and Accounting 0.1×
- Social Sciences 0.1×
- Materials Science 0.0×
- Environmental Science 0.0×
Who are the top researchers at Providence Portland Medical Center?
Ranked on the composite score, Walter J. Urba, R. Bryan Bell and Bernard A. Fox lead among researchers whose main affiliation is Providence Portland Medical Center.
- 1 Walter J. Urba United States · #6,943 worldwide 1.4k citations · 57 works
- 2 R. Bryan Bell United States · #40,509 worldwide 236 citations · 61 works
- 3 Bernard A. Fox United States · #57,595 worldwide 313 citations · 55 works
- 4 Andrew D. Weinberg United States · #73,556 worldwide 315 citations · 40 works
- 5 Michael J. Gough United States · #81,791 worldwide 216 citations · 52 works
- 6 David N. Gilbert United States · #91,233 worldwide 179 citations · 35 works
- 7 John E. Godwin United States · #148,928 worldwide 177 citations · 24 works
- 8 Eric Tran United States · #160,709 worldwide 109 citations · 24 works
- 9 Marka R. Crittenden United States · #189,233 worldwide 171 citations · 22 works
- 10 John W. Smith United States · #195,216 worldwide 133 citations · 27 works
Which keywords describe research at Providence Portland Medical Center?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Tumor Microenvironment, Cancer Immunotherapy, Immune Checkpoint Blockade, PD-1 and PD-L1, Immunotherapy, Immunity, Antigen Presentation and Innate Immunity.
- Tumor Targeting
- PET Imaging
- Monoclonal Antibodies
- Cetuximab
- Cell-Free DNA
- Genomic Instability
- Cancer Therapy
- Precision Medicine
- Natural Killer Cells
- Inflammation
- Cancer
- Chimeric Antigen Receptor
- Leukemia
- Lymphoma
- Chemotherapy
- Tumor Antigen
- Innate Immunity
- Immunity
- PD-1 and PD-L1
- Cancer Immunotherapy
- Tumor Microenvironment
- Immune Checkpoint Blockade
- Immunotherapy
- Antigen Presentation
- Dendritic Cells
- Vaccine Adjuvants
- Tumor Regression
- Epidemiology
- CAR T Cells
- Targeted Therapy
- Prognostic Factors
- NK Cell Recognition
- Radiotherapy
- Clinical Trials
- Surgical Management
- Breast Cancer
- Cancer Genomics
- Gene Therapy
- Mutational Signatures
- Neoadjuvant Therapy
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Tumor Microenvironment24▲ 31×8 topics
- Cancer Immunotherapy23▲ 85×3 topics
- Immune Checkpoint Blockade20▲ 103×1 topic
- PD-1 and PD-L120▲ 103×1 topic
- Immunotherapy18▲ 15×15 topics
- Immunity16▲ 23×5 topics
- Antigen Presentation14▲ 94×2 topics
- Innate Immunity14▲ 26×5 topics
- Dendritic Cells13▲ 84×2 topics
- Tumor Antigen13▲ 122×1 topic
- Vaccine Adjuvants13▲ 122×1 topic
- Chemotherapy12▲ 9.7×17 topics
- Tumor Regression11▲ 59×2 topics
- Lymphoma10▲ 35×3 topics
- Epidemiology10▲ 1.40×42 topics
- Leukemia9▲ 63×2 topics
- CAR T Cells9▲ 72×1 topic
- Chimeric Antigen Receptor9▲ 72×1 topic
- Targeted Therapy8▲ 21×5 topics
- Cancer8▲ 3.3×23 topics
- Prognostic Factors8▲ 9.9×13 topics
- Inflammation7▲ 1.98×28 topics
- NK Cell Recognition6▲ 53×1 topic
- Natural Killer Cells6▲ 53×1 topic
- Radiotherapy6▲ 8.8×12 topics
- Precision Medicine5▲ 6.3×4 topics
- Clinical Trials5▲ 4.0×7 topics
- Cancer Therapy4▲ 4.4×11 topics
- Surgical Management4▲ 6.0×10 topics
- Genomic Instability4▲ 21×3 topics
- Breast Cancer4▲ 9.8×6 topics
- Cell-Free DNA4▲ 22×2 topics
- Cancer Genomics4▲ 28×1 topic
- Cetuximab4▲ 25×2 topics
- Gene Therapy4▲ 11×5 topics
- Monoclonal Antibodies4▲ 23×3 topics
- Mutational Signatures4▲ 28×1 topic
- PET Imaging4▲ 12×4 topics
- Neoadjuvant Therapy3▲ 8.3×5 topics
- Tumor Targeting3▲ 11×3 topics
Which research topics does Providence Portland Medical Center publish most on?
By volume in 2022–2025: Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, CAR-T cell therapy research and Immune Cell Function and Interaction.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Immunotherapy and Biomarkers Oncology 20 works
- 2 Immunotherapy and Immune Responses Immunology 13 works
- 3 CAR-T cell therapy research Oncology 9 works
- 4 Immune Cell Function and Interaction Immunology 6 works
- 5 Cancer Genomics and Diagnostics Cancer Research 4 works
- 6 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 3 works
- 7 Immune cells in cancer Immunology 3 works
- 8 T-cell and B-cell Immunology Immunology 2 works
- 9 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 2 works
- 10 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Providence Portland Medical Center's research output changed?
Output in 2018–2022 was 19% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Portland
- Oregon Health & Science University
- Portland State University
- University of Portland
- Lewis & Clark College
- Reed College
- Portland VA Medical Center
- Pacific Northwest Research Station
- Oregon Medical Research Center
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.